|
인쇄하기
취소
|
Drug regulator to map out clinical guideline on hepatitis B drugs
Published: 2013-06-21 06:56:00
Updated: 2013-06-21 06:56:00
The Ministry of Food and Drug Safety (MFDS) said Wednesday it will draw up a new guideline to specify in detail the assessment of hepatitis B drugs in local clinical trials.
So far, the ministry has updated the country’s clinical guidelines about the assessment of antiviral agents, which is harmonious with the common technical document published by the International Conference on Harmonizati...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.